Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
WisdomTree BioRevolution Fund
Similar ETFs
Trading data
WDNA performance and flow charts
Performance
Flows
Historic performance and flows
Data as of March 11, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | -0.46% | +4.60% | +4.96% | +38.09% | +12.49% | |
| Flows | -$357K | -$357K | -$357K | -$357K | -$524K | - |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +22.81% | +28.57% | +24.57% | |
Max drawdown | -8.60% | -17.47% | -37.80% | |
Max drawdown duration | 48d | 106d | 901d | N/A |
Time to recover | N/A | 85d | 273d | N/A |
Replication quality
Data as of March 12, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
Exposure
Data as of January 31, 2026Countries
Sectors
Diversification
Total weight of top 15 holdings out of 85
Top 15 Holdings
Characteristics
The WisdomTree BioRevolution Fund is built to track the WisdomTree BioRevolution NTR Index. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly).
This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Provider | WisdomTree |
| N° of holdings | 85 |
| Replication method | Direct (Physical) |
| Asset class | Equities |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | June 3, 2021 |
| ESG | No |
What type of ETF is WDNA?
WDNA is a Passive ETF that provides exposure to Equity assets. It is managed by WisdomTree.
What index does WDNA track?
WDNA tracks the WisdomTree BioRevolution NTR Index, aiming to replicate its performance through optimized sampling.
What does WDNA invest in?
This ETF provides exposure to Other Developed markets Equities. It is part of the segment: BioTech & Genomics.
What is the expense ratio of WDNA?
The total expense ratio (TER) of WDNA is 0.45%, representing the annual fee charged by the fund manager.
When was WDNA launched?
WDNA was launched on June 3, 2021, marking its entry into the ETF market.
Who is the issuer of WDNA?
WDNA is issued by WisdomTree.
What is the AUM of WDNA?
As of March 11, 2026, WDNA manages $2.31 M, reflecting the total assets held in the fund.
How has WDNA performed recently?
As of March 11, 2026, WDNA delivered a return of -0.46% over the past month (1M performance), 4.6% over the past three months (3M), and 4.96% year-to-date (YTD).
What are the recent fund flows for WDNA?
As of March 11, 2026, WDNA has seen net flows of -$357K in the past month (1M flow) and -$357K year-to-date (YTD).
Does WDNA pay dividends?
As of March 11, 2026, WDNA has a trailing 12-month distribution yield of 4.34%.
How many holdings are in WDNA
As of January 31, 2026, WDNA holds 85 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is WDNA?
As of January 31, 2026, WDNA holds 85 securities, with 37.91% of its assets concentrated in its top 15 holdings.
What are the top holdings of WDNA?
As of January 31, 2026, WDNA holds a portfolio of 85 underlyings, with its largest positions including US86366E1064, MODERNA INC and NATERA. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does WDNA invest in?
As of January 31, 2026, WDNA has its largest geographic exposures in USA.
What sectors or themes does WDNA focus on?
As of January 31, 2026, WDNA is primarily exposed to Health Care.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring
Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.
What’sTheFund
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).
What’sTheFund
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).
What’sTheFund
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).
Browse all educational columns
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
